YOUR FRIENDS' ACTIVITY

    Intel Profit Top Forecasts; Sales Outlook Misses

    RELATED QUOTES

    SymbolPriceChange
    INTC23.923-0.13
    MSFT34.2690.12

    Intel (INTC) reported quarterly earnings that beat analysts' estimates and revenue that met forecasts, but its revenue outlook fell short of expectations on Thursday.

    After the fourth-quarter earnings announcement, Intel stock ticked higher in extended-hours trading. (Click here to get the latest quotes for the company.) (INTC)

    The chipmaker's net earnings were $2.5 billion, or 48 cents a share, compared with $3.4 billion, or 64 cents a share, in the same quarter last year.

    Revenue decreased 3 percent to $13.5 billion from $13.89 billion a year ago as the personal computer industry wrestles with falling sales and a shift toward tablets and smartphones.

    Analysts had expected the company to report earnings excluding items of 45 cents a share on $13.53 billion in revenue, according to a consensus estimate from Thomson Reuters.

    For the first quarter, the company sees revenue of $12.2 to $13.2 billion. This range's midpoint is lower than the consensus estimate of $12.91 billion, according to a consensus estimate from Thomson Reuters.

    PC makers are struggling to stop a decline in sales as consumers hold off on buying new laptops in favor of spending on more nimble mobile gadgets.

    Microsoft's (MSFT) long-awaited launch of Windows 8 in October brought touchscreen features to laptops but failed to spark a resurgence in sales that Intel and many PC manufacturers had hoped for.

    Intel said its capital spending in 2013 would be $13 billion, plus or minus $500 million, exceeding what many analysts had expected.



    More From CNBC
    Also Read

    Market Data

    • Currencies
      Currencies
      NamePriceChange% Chg
      0.96510.00+0.01%
      AUDUSD=X
      0.63800.00+0.04%
      AUDGBP=X
      0.74610.00+0.03%
      AUDEUR=X
    • Commodities
      Commodities
      NamePriceChange% Chg
      1,453.60-8.80-0.60%
      GCJ13.CMX
      28.58-0.21-0.73%
      SIH13.CMX
      3.450.02+0.51%
      HGH13.CMX
      93.300.34+0.37%
      CLJ13.NYM